Capella 4045 Assessment 3

Name

Capella university

NURS-FPX4045 Nursing Informatics: Managing Health Information and Technology

Prof. Name

Date

Introduction to the Chosen Technology in Nursing

Digital inhalers are an emerging healthcare technology that can help patients with asthma and chronic obstructive pulmonary disease (COPD) monitor medication use, improve adherence, and share useful treatment data with healthcare professionals. By combining inhaler devices with sensors and digital monitoring capabilities, this technology can provide information about when and how medications are used, allowing nurses and other clinicians to identify adherence concerns and support more individualized respiratory care (Kahnert et al., 2023).

The use of digital inhalers is particularly relevant to nursing because asthma and COPD often require long-term medication management and ongoing patient education. Traditional care approaches may depend heavily on patients accurately remembering and reporting their medication use. Digital inhalers can supplement this process by generating objective medication-use data that can be reviewed during clinical encounters or incorporated into remote patient monitoring programs.

Capella 4045 Assessment 3

The selection of digital inhalers for this evidence-based project was influenced by Sentinel U simulation scenarios involving the patient Lynn Tan. These scenarios demonstrated how digital health technologies can provide information that supports clinical decision-making and patient-centered care. To examine the role of digital inhalers further, a review of scholarly literature was conducted using Capella University’s library and databases such as PubMed, CINAHL, and SpringerLink. Search terms included “smart inhalers,” “digital inhalers,” “COPD remote technology,” and “asthma adherence tools.” The literature review focused primarily on recent peer-reviewed research examining the clinical applications, benefits, and implementation considerations associated with digital inhalers.

Foundational Assumptions

This evidence-based project is based on the assumption that digital inhalers can support medication adherence and provide healthcare professionals with more timely information about respiratory disease management. The technology does not replace clinical assessment or patient education; instead, it can supplement these activities by providing additional information about medication-use patterns.

Another assumption is that integrating digital technology into asthma and COPD management may strengthen communication between patients and healthcare professionals. When adherence information is available, nurses can use it to identify potential barriers, reinforce education, and discuss treatment concerns with patients.

The project also recognizes that successful implementation depends on more than the availability of technology. Healthcare organizations must consider staff training, patient acceptance, privacy, data security, cost, infrastructure, and workflow integration. Digital inhalers are therefore best viewed as one component of a broader patient-centered chronic disease management strategy.

Evidence From the Literature

Anticevich et al. (2023)

Anticevich et al. (2023) examined digital solutions for asthma and COPD management, including wearable technologies that can collect and communicate health information. These technologies may support real-time monitoring and provide clinicians with additional information for identifying changes in a patient’s condition.

From a nursing perspective, access to timely digital information can contribute to more individualized care planning. Nurses may use available data to reinforce self-management education, identify concerns that require follow-up, and communicate relevant information with other members of the healthcare team. The article was selected because it provides a broad discussion of how digital technologies may address persistent challenges in chronic respiratory disease management.

Eikholt et al. (2023)

Eikholt et al. (2023) reviewed electronic monitoring devices designed to support inhaler use and provide feedback regarding inhalation technique. The review highlights the potential value of electronic monitoring for patient education because patients can receive information about their medication-use behaviors rather than relying solely on memory or self-report.

For nurses, this technology can create opportunities for targeted education. However, implementation also requires consideration of factors such as affordability, patient preferences, usability, reimbursement, and integration with existing clinical workflows. These considerations are important because a technology is unlikely to improve outcomes if patients cannot use it consistently or healthcare professionals cannot incorporate its data into routine care.

Mosnaim et al. (2022)

Mosnaim et al. (2022) examined digital inhalers and remote patient monitoring in asthma care. Digital approaches can provide information about medication use and create opportunities for healthcare professionals to identify adherence concerns between routine visits.

This evidence is relevant to nursing practice because medication adherence is an important component of chronic respiratory disease management. When nurses have access to appropriate adherence information, they can address potential barriers through patient education, communication, and individualized follow-up. Digital monitoring can therefore complement, rather than replace, traditional nursing interventions.

Long et al. (2023)

Long et al. (2023) discussed the broader role of digital health technologies in COPD management. Digital tools can support medication monitoring, communication, self-management, and coordination of care. These functions may help healthcare professionals obtain information that is not always available during periodic clinical appointments.

The authors also identify challenges associated with digital health implementation. Technology acceptance, usability, access, and integration into healthcare systems can influence whether digital interventions achieve their intended benefits. For nurses, these issues reinforce the importance of assessing both the clinical value of technology and the patient’s ability and willingness to use it.

Ramachandran et al. (2023)

Ramachandran et al. (2023) examined barriers and facilitators affecting the adoption of digital health interventions for COPD management. Their findings emphasize that successful implementation requires attention to organizational, technological, and patient-related factors.

Nurses can contribute to successful implementation by helping patients understand how digital tools work, identifying barriers to adoption, and communicating patient feedback to organizational leaders and interdisciplinary teams. The review is particularly useful because it considers implementation challenges rather than focusing exclusively on the potential benefits of digital health technology.

The Role of Artificial Intelligence in Digital Inhalers

Artificial intelligence (AI) can expand the capabilities of digital inhalers by helping healthcare systems process large amounts of information generated through digital monitoring. Rather than simply recording medication use, AI-supported systems may analyze patterns in adherence and other available health data to identify trends that warrant further clinical attention.

For example, an AI-enabled system could identify repeated missed doses or changes in medication-use patterns and generate an alert for appropriate follow-up. This could help nurses prioritize patients who may need additional education or assessment. However, AI-generated alerts should support—not replace—professional clinical judgment. Nurses must consider the patient’s symptoms, history, treatment plan, and other clinical information before making care decisions.

The combination of AI and digital inhaler technology may also contribute to more personalized chronic disease management. By identifying patterns over time, digital systems can provide information that helps healthcare professionals tailor education and follow-up to individual patient needs. The effectiveness of these approaches, however, depends on the quality of the underlying data, appropriate clinical oversight, patient privacy protections, and successful integration into healthcare workflows.

Evidence-Based Recommendations for Nursing Practice

The reviewed literature supports considering digital inhalers as part of comprehensive asthma and COPD management. Their primary value is the ability to provide additional information about medication use and support communication between patients and healthcare professionals. For nurses, these data can complement assessment, patient education, adherence counseling, and follow-up.

Digital inhalers may be particularly useful when patients experience difficulties with medication adherence or require ongoing support with chronic disease self-management. Nurses can review available information with patients, discuss barriers to treatment adherence, reinforce proper medication use, and determine whether additional clinical evaluation is necessary.

Implementation should also include appropriate education for both patients and healthcare professionals. Nurses need to understand how the technology works, what information it provides, how to interpret available data, and when information should prompt further assessment. Patients should receive clear instructions regarding device use, data sharing, privacy, and the purpose of monitoring.

Healthcare organizations should also evaluate several implementation considerations:

• Staff education and competency with digital inhaler technology.
• Patient access, affordability, and technology literacy.
• Privacy and security of remotely collected health information.
• Compatibility with existing electronic health records and workflows.
• Organizational policies governing digital monitoring and data use.
• Reimbursement and long-term sustainability.
• Patient preferences and willingness to participate in digital monitoring.

Organizational leadership is important because adopting digital inhalers may require changes to workflows, staff responsibilities, training, and information-management processes. A structured implementation approach can help ensure that the technology supports clinical practice rather than creating unnecessary administrative demands.

Implications for Nursing and Patient-Centered Care

Digital inhalers can support a shift from episodic respiratory care toward more continuous monitoring and self-management. Instead of relying exclusively on information collected during office visits, healthcare professionals may have access to additional data that describes medication-use patterns between encounters.

For nurses, this creates opportunities to strengthen patient education and early intervention. Nurses can use technology-generated information as a starting point for conversations about adherence, inhaler technique, treatment barriers, and symptom management. This approach also supports patient participation because individuals can become more aware of their own medication-use patterns and participate more actively in managing their condition.

At the same time, digital inhalers should not be viewed as a universal solution. Technology can introduce barriers related to cost, usability, digital literacy, privacy, and access. Patient preferences and individual circumstances should therefore remain central to implementation decisions.

Conclusion

Digital inhalers represent a developing technology with potential applications in the management of asthma and COPD. By recording medication-use information and supporting remote monitoring, these devices can provide nurses and other healthcare professionals with additional data for patient education, adherence support, and care coordination. Evidence from recent literature also highlights important implementation considerations, including usability, cost, organizational readiness, privacy, training, and integration into clinical workflows.

For nursing practice, the greatest value of digital inhalers may come from combining technology-generated information with professional assessment and patient-centered communication. When appropriately implemented, digital inhalers can complement existing chronic disease management strategies while supporting patients in developing more informed and consistent self-management behaviors.

References

Anticevich, S., Bakerly, N. D., Chrystyn, H., Hew, M., & Palen, J. (2023). Advancing digital solutions to overcome longstanding barriers in asthma and COPD management. Patient Preference and Adherence, 17, 259–272. https://doi.org/10.2147/PPA.S385857

Eikholt, A. A., Hew, M., & van Boven, J. F. M. (2023). Electronic monitoring devices to support inhalation technique in patients with asthma: A narrative review. Current Treatment Options in Allergy, 10(1), 28–52. https://doi.org/10.1007/s40521-023-00328-7

Kahnert, K., et al. (2023). Use of smart inhalers in respiratory disease. [Reference details should be verified against the original Capella University library source.]

Capella 4045 Assessment 3

Long, H., Li, S., & Chen, Y. (2023). Digital health in chronic obstructive pulmonary disease. Chronic Diseases and Translational Medicine, 9(2), 90–103. https://doi.org/10.1002/cdt3.68

Mosnaim, G. S., Greiwe, J., Jariwala, S. P., Pleasants, R., & Merchant, R. (2022). Digital inhalers and remote patient monitoring for asthma. The Journal of Allergy and Clinical Immunology: In Practice, 10(10), 2525–2533. https://doi.org/10.1016/j.jaip.2022.06.026

Ramachandran, H., Oh, J. L., Cheong, Y. K., Jiang, Y., Teo, J. Y. C., Seah, C. W. A., Yu, M., & Wang, W. (2023). Barriers and facilitators to the adoption of digital health interventions for COPD management: A scoping review. Heart & Lung, 59, 117–127. https://doi.org/10.1016/j.hrtlng.2023.02.004